cART durability and causes for treatment switching or discontinuation in HIV-positive patients older than 50 years of age

J Acquir Immune Defic Syndr. 2010 Oct;55(2):e12-4. doi: 10.1097/QAI.0b013e3181ef791b.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Age Factors
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active* / adverse effects
  • Confidence Intervals
  • HIV Infections / drug therapy*
  • Humans
  • Middle Aged
  • Odds Ratio
  • Time Factors
  • Viral Load / drug effects

Substances

  • Anti-HIV Agents